Survival in double hit and double expressor diffuse large B cell lymphoma

Overall survival in 307 patients with diffuse large B cell lymphoma according to molecular subtype. Double hit lymphoma (DHIT) were those that had translocations of MYC and BCL2. The MYC+/BCL2+ lymphoma subgroup included those that expressed both MYC and BCL2 on immunohistochemistry and excluded those meeting the requirements for DHIT. Four DHIT patient cases had no MYC protein expression; one had a missing value for BCL2 protein expression.